Clinical Trial Update: Assessing the Impact of the Microbiome on Breast Cancer Radiotherapy Toxicity

View source ↗

Summary

Completed clinical trial assessing the impact of the microbiome on radiotherapy toxicity in breast cancer (DCIS and invasive breast cancer) patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ductal Carcinoma in Situ
• Invasive Breast Cancer

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: DCIS, Invasive Breast Cancer | Status: COMPLETED